U.S. officially approves Pfizer's COVID-19 vaccine
Updated: Dec 12, 2020
The US Government Advisory Panel recommended that Pfizer COVID-19 be licensed for use.
The vote by the Food and Drug Administration to approve the approval of the vaccine
is the penultimate hurdle before the start of the largest vaccination program in US history.
On Friday, according to three people with knowledge of the decision who spoke on condition of anonymity because they were not allowed to disclose it the Food and Drug Administration allowed Pfizer's Covid-19 vaccine for emergency use. The action ensures that millions of people who are particularly vulnerable will start getting the vaccine within days.
In a vote of 17-4 with one abstention, the Advisory Group voted yes to the question Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine outweigh its risks for use in individuals 16 years of age and older?"
The authorization is a historic turning point in a pandemic in the United States that has destroyed more than 290,000 lives. The United States becomes the sixth nation to clear the vaccine with the decision, in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico. Other authorisations are due within weeks,
including those from the European Union.
An initial shipment of about 2.9 million doses of the vaccine will be sent around the United States over the next week.